Literature DB >> 1371776

Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.

T A Aasmundstad1, O A Haugen, E Johannesen, A L Høe, S Kvinnsland.   

Abstract

AIMS: To compare oestrogen receptor measurements on fresh tissue done by an enzyme immunoassay (ER-EIA, Abbott) and an immunohistochemical technique (ER-ICA, Abbott) using formalin fixed, paraffin was embedded material.
METHODS: The ER-EIA is based on a sandwich immunoassay using fresh frozen tissue, and the absorbance values were read by a Quantum Analyzer. Sections were cut from the corresponding paraffin wax blocks, and after pretreatment with pronase and DNase, the slides were incubated with monoclonal oestrogen antibody. The immunoperoxidase staining was scored semiquantitatively, incorporating both the intensity and percentage of positive staining (HSCORE).
RESULTS: HSCORE rating of the ER-ICA slides gave a significant correlation with the quantitative ER-EIA values (r = 0.76; p less than 0.001). The overall sensitivity and specificity of the immunohistochemical method was 88% and 93%, respectively.
CONCLUSIONS: ER-ICA on routinely processed material can be a valuable alternative when biochemical analysis of oestrogen receptor content is not available. Furthermore, immunohistochemical staining identifies oestrogen receptor positivity at a cellular level, which ensures that the analysed material is representative. This technique could therefore be particularly valuable in small tumours and in situ lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371776      PMCID: PMC495650          DOI: 10.1136/jcp.45.2.125

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors.

Authors:  L Cheng; S W Binder; Y S Fu; K J Lewin
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

2.  The unmasking of antigens in paraffin sections of tissue by trypsin.

Authors:  R C Curran; J Gregory
Journal:  Experientia       Date:  1977-10-15

3.  Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction.

Authors:  I P Shintaku; J W Said
Journal:  Am J Clin Pathol       Date:  1987-02       Impact factor: 2.493

Review 4.  Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.

Authors:  D C Allred; M A Bustamante; C O Daniel; H V Gaskill; A B Cruz
Journal:  Arch Surg       Date:  1990-01

Review 5.  Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature.

Authors:  A Kauppila
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

6.  Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.

Authors:  L P Pertschuk; D S Kim; K Nayer; J G Feldman; K B Eisenberg; A C Carter; Z T Rong; W L Thelmo; J Fleisher; G L Greene
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

7.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

8.  Survival with breast cancer: the importance of estrogen receptor quantity.

Authors:  L L Shek; W Godolphin
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

9.  Monoclonal antibodies to human estrogen receptor.

Authors:  G L Greene; C Nolan; J P Engler; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

Authors:  M R Williams; J H Todd; I O Ellis; C S Dowle; J L Haybittle; C W Elston; R I Nicholson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

  10 in total
  13 in total

1.  Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy.

Authors:  L E Borges; A W Horne; S E McDonald; J L V Shaw; P C Lourenco; F Petraglia; H O D Critchley
Journal:  Reprod Sci       Date:  2010-10-26       Impact factor: 3.060

2.  Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.

Authors:  Marylène Lejeune; Joaquín Jaén; Lluis Pons; Carlos López; Maria-Teresa Salvadó; Ramón Bosch; Marcial García; Patricia Escrivà; Jordi Baucells; Xavier Cugat; Tomás Alvaro
Journal:  J Anat       Date:  2008-06       Impact factor: 2.610

3.  Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.

Authors:  H C van Doorn; C W Burger; P van der Valk; H M Bonfrèr
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

4.  Expression of the c-Met Proteins in Malignant Skin Cancers.

Authors:  Yoon-Jin Lee; Dae-Hyun Kim; Sang-Han Lee; Dong-Wook Kim; Hae-Seon Nam; Moon Kyun Cho
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

5.  Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.

Authors:  Yogesh M Bramhecha; Karl-Philippe Guérard; Étienne Audet-Walsh; Shaghayegh Rouzbeh; Ola Kassem; Erwan Pernet; Eleonora Scarlata; Lucie Hamel; Fadi Brimo; Maziar Divangahi; Armen G Aprikian; Simone Chevalier; Vincent Giguère; Jacques Lapointe
Journal:  Oncogene       Date:  2022-04-11       Impact factor: 9.867

6.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

7.  The presence and regulation of connective tissue growth factor in the human endometrium.

Authors:  J A Maybin; J Barcroft; U Thiruchelvam; N Hirani; H N Jabbour; H O D Critchley
Journal:  Hum Reprod       Date:  2012-02-09       Impact factor: 6.918

8.  Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder.

Authors:  Naomi Sato; Kazue Ise; Shuko Hata; Shinichi Yamashita; Akihiro Ito; Hironobu Sasano; Yasuhiro Nakamura
Journal:  Pathol Oncol Res       Date:  2021-04-15       Impact factor: 3.201

9.  PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.

Authors:  Khalil Choucair; Joshua Ejdelman; Fadi Brimo; Armen Aprikian; Simone Chevalier; Jacques Lapointe
Journal:  BMC Cancer       Date:  2012-11-22       Impact factor: 4.430

10.  Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

Authors:  D N Poller; D R Snead; E C Roberts; M Galea; J A Bell; A Gilmour; C W Elston; R W Blamey; I O Ellis
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.